Crestline Management, L.P. 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Crestline Management, L.P. disclosed 3 US equity positions worth $62.6m in its Q2 2025 13F filing. The largest position was DNLI at 86.3% of the reported book, followed by SANA and EGHT. Against the Q1 2025 filing, it opened 0 new positions, added to 0 and reduced 2 among the top 3 holdings.
What did Crestline Management, L.P. own in Q2 2025? Top 3 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | DNLI DENALI THERAPEUTICS INC | Healthcare | 86.3% | $54.0m | 3,860,732 | -7% | reduced |
| 2 | SANA SANA BIOTECHNOLOGY INC | Healthcare | 10.6% | $6.6m | 2,420,937 | -13% | reduced |
| 3 | EGHT 8X8 INC NEW | Technology | 3.1% | $1.9m | 990,580 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.